Caricamento...
Novel DNA targeted therapies for head and neck cancers: clinical potential and biomarkers
Head and neck squamous cell carcinoma is the sixth most common cancer worldwide and despite advances in treatment over the last years, there is still a relapse rate of 50%. New therapeutic agents are awaited to increase the survival of patients. DNA repair targeted agents in combination with standar...
Salvato in:
| Pubblicato in: | Oncotarget |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Impact Journals LLC
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5655317/ https://ncbi.nlm.nih.gov/pubmed/29113422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20953 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|